Holen Sie sich die Stockscreener-App
16.16
0.62%
-0.10
Handel nachbörslich:
16.16
Spyre Therapeutics Inc-Aktien (SYRE) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-08-04 | $17.01 | $15.81 | $1.20 | 728,922.0 | -0.62% |
| 2025-08-01 | $17.04 | $16.23 | $0.805 | 551,674.0 | -4.18% |
| 2025-07-31 | $17.32 | $16.57 | $0.7465 | 599,802.0 | -1.85% |
| 2025-07-30 | $17.70 | $16.78 | $0.92 | 884,505.0 | +3.10% |
| 2025-07-29 | $17.20 | $16.43 | $0.775 | 472,722.0 | -1.24% |
| 2025-07-28 | $18.00 | $16.84 | $1.16 | 641,898.0 | -4.55% |
| 2025-07-25 | $17.95 | $17.06 | $0.89 | 841,400.0 | +1.08% |
| 2025-07-24 | $18.30 | $17.38 | $0.925 | 541,164.0 | -1.18% |
| 2025-07-23 | $18.03 | $17.62 | $0.41 | 138,008.0 | +8.00% |
| 2025-07-22 | $16.73 | $16.16 | $0.57 | 654,412.0 | +0.86% |
| 2025-07-21 | $17.09 | $16.23 | $0.86 | 513,550.0 | +0.37% |
| 2025-07-18 | $17.18 | $16.08 | $1.11 | 333,115.0 | -3.55% |
| 2025-07-17 | $16.89 | $16.21 | $0.68 | 475,304.0 | +4.26% |
| 2025-07-16 | $16.27 | $15.44 | $0.83 | 382,460.0 | +5.81% |
| 2025-07-15 | $17.09 | $15.05 | $2.04 | 703,584.0 | -6.70% |
| 2025-07-14 | $16.55 | $15.61 | $0.945 | 520,177.0 | +4.59% |
| 2025-07-11 | $15.96 | $15.47 | $0.49 | 491,411.0 | -1.69% |
| 2025-07-10 | $16.57 | $15.83 | $0.735 | 482,877.0 | -3.56% |
| 2025-07-09 | $16.92 | $15.79 | $1.13 | 566,300.0 | +6.02% |
| 2025-07-08 | $16.10 | $15.37 | $0.7331 | 555,714.0 | +2.03% |
Spyre Therapeutics Inc-Aktien (SYRE) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Spyre Therapeutics Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der SYRE-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Spyre Therapeutics Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Spyre Therapeutics Inc-Aktien (SYRE) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-08 | $17.04 | $15.81 | $1.22 | 2,009,518.0 | -4.77% |
| 2025-07 | $18.30 | $14.00 | $4.30 | 12,397,594.0 | +13.36% |
| 2025-06 | $19.20 | $13.93 | $5.27 | 12,638,190.0 | -2.03% |
| 2025-05 | $15.77 | $12.29 | $3.48 | 10,197,865.0 | +0.33% |
| 2025-04 | $16.12 | $10.91 | $5.21 | 17,251,629.0 | -5.61% |
| 2025-03 | $21.03 | $16.13 | $4.90 | 13,287,855.0 | -18.10% |
| 2025-02 | $24.83 | $18.26 | $6.57 | 10,925,495.0 | -14.31% |
| 2025-01 | $26.01 | $20.25 | $5.76 | 11,749,605.0 | -1.25% |
Spyre Therapeutics Inc-Aktien (SYRE) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $29.06 | $22.37 | $6.69 | 9,847,302.0 | -20.72% |
| 2024-11 | $40.26 | $25.74 | $14.52 | 14,404,771.0 | -12.60% |
| 2024-10 | $36.60 | $26.28 | $10.32 | 8,567,734.0 | +10.61% |
| 2024-09 | $31.89 | $26.52 | $5.37 | 12,800,810.0 | +2.30% |
| 2024-08 | $29.00 | $23.31 | $5.69 | 8,943,039.0 | +4.55% |
| 2024-07 | $32.41 | $23.00 | $9.41 | 11,316,523.0 | +16.97% |
| 2024-06 | $38.90 | $22.19 | $16.71 | 20,949,923.0 | -32.73% |
| 2024-05 | $40.49 | $31.39 | $9.11 | 6,780,000.0 | +5.81% |
| 2024-04 | $40.84 | $31.27 | $9.57 | 6,849,784.0 | -12.92% |
| 2024-03 | $47.97 | $28.48 | $19.49 | 14,248,629.0 | +38.23% |
| 2024-02 | $28.80 | $20.07 | $8.73 | 9,579,014.0 | +5.91% |
| 2024-01 | $28.66 | $18.54 | $10.12 | 6,339,820.0 | +20.40% |
Spyre Therapeutics Inc-Aktien (SYRE) Preisverlauf 2023
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2023-12 | $22.66 | $14.22 | $8.44 | 3,057,713.0 | +15.33% |
| 2023-11 | $19.60 | $10.42 | $9.18 | 339,919.0 | +0.00% |
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):